Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cardinal Health (NY:CAH)

148.22 +0.95 (+0.65%)
Official Closing Price Updated: 4:10 PM EDT, May 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cardinal Health

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Distributors Agree to Opioid Settlement With Washington State
From McKesson Corporation
Via Business Wire
San Francisco To Start Opioid Epidemic Trial Against Teva, Walgreen: Reuters
Via Benzinga
President Biden To Outline Strategy To Tackle Drug Addiction, Overdose: Reuters
Via Benzinga
10 Stocks That Moved From Thursday's CNBC's 'Fast Money: Halftime Report'
CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors. 
Via Benzinga
Should Value Investors Pick Cardinal Health (CAH) Stock Now?
Cardinal Health is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front. 
Via Talk Markets
Expert Ratings For Cardinal Health
Analysts have provided the following ratings for Cardinal Health (NYSE:CAH) within the last quarter: 
Via Benzinga
Where Cardinal Health Stands With Analysts
Analysts have provided the following ratings for Cardinal Health (NYSE:CAH) within the last quarter: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2022
Upgrades 
Via Benzinga
Hostess Brands Appoints Travis Leonard As Finance Chief
Hostess Brands Inc (NASDAQ: TWNK) has appointed Travis Leonard as the Chief Financial Officer (CFO), effective May 11, 2022. Leonard will succeed interim CFO... 
Via Benzinga
Recap: Cardinal Health Q2 Earnings
  Cardinal Health (NYSE:CAH) reported its Q2 earnings results on Thursday, February 3, 2022 at 06:45 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Scheduled For February 3, 2022
Companies Reporting Before The Bell • Tuesday Morning (NASDAQ:TUEM) is likely to report earnings for its second quarter. 
Via Benzinga
West Virginia Says J&J, Teva, AbbVie Caused 'Tsunami' Of Opioid Addiction: Reuters
West Virginia's attorney general urged a judge to hold Johnson & Johnson (NYSE: JNJ), Teva Pharmaceuticals Industries Ltd (NYSE: TEVA), and AbbVie Inc's (NYSE: 
Via Benzinga
This Favorable Sign Appears On Cardinal Health's Chart
If history is any guide, there may be good fortune ahead for shares of Cardinal Health (NYSE:CAH). A so-called "golden cross" has formed on its chart and, not surprisingly, this... 
Via Benzinga
High Inflation And Dividend Stocks: Is It Time For Coca-Cola And Exxon Mobil To Shine?
One potential way for investors to offset the impact of inflation is to look to stocks with high dividend yields. 
Via Talk Markets
High Inflation And Dividend Stocks: Is It Time For Coca-Cola And Exxon Mobil To Shine?
Inflation can be a nuisance for investors, eating away at portfolio returns. The U.S. Labor Department reported a 7.5% increase in the consumer pri... 
Via Benzinga
Johnson & Johnson Sees A Strong Move: Is It Ready For A Breakout?
Johnson & Johnson (NYSE:JNJ) shares are trading high... 
Via Benzinga
Drug Distributors, JNJ Agree To Settle $26B Opioid Lawsuits
Distributors McKesson Corporation (NYSE: MCK), AmerisourceBergen Corp (NYSE: ABC), Cardinal Health Inc (NYSE: CAH), and Johnson & Johnson (NYSE:... 
Via Benzinga
Distributors Approve Opioid Settlement Agreement
From AmerisourceBergen and Cardinal Health and McKesson Corporation
Via Business Wire
Dividend Income Update January 2022
With February already underway it is time for all dividend income investors to look back at the previous month and see how much passive dividend income our portfolios generated. 
Via Talk Markets
Daily Report: Cardinal Health (CAH)
CAH's recent $51.96 share price might rise by $4.04 to reach $56.00 by February 7, 2023. This estimate is just eight cents under the median of one-year target single share prices from 13 analysts... 
Via Talk Markets
Stock Market Rally Volatile; Google, Facebook, Amazon, Snap Are Earnings Movers: Weekly Review
The major indexes slashed weekly gains after Monday's follow-through day. 
Via Investor's Business Daily
Cardinal Health's Q4 Earnings Hit By Inflationary Impacts, Supply Chain Constraints; Lowers FY22 Outlook
Cardinal Health (NYSE: CAH) has reported Q2 FY22 adjuste 
Via Benzinga
Johnson & Johnson, Distributors Reach $590M Opioid Settlement For Tribe Claims: Report
Johnson & Johnson (NYSE: JNJ) and the three U.S. 
Via Benzinga
Cardinal Health's Earnings Outlook
Cardinal Health (NYSE:CAH) is set to give its latest quarterly earnings report on Thursday, 2022-02-03. Here's what investors need to know before the announcement. Analysts estimate that Cardinal... 
Via Benzinga
McKesson Stock, AmerisourceBergen Stock Hold Up With Earnings Due
Investors will watch McKesson and AmerisourceBergen for updates on opioid settlements 
Via Investor's Business Daily
BioCorRx Aims To Help Combat Opioid Crisis With Implantable Naltrexone Drug Candidate BICX104
Image provided by BioCorRx of a naltrexone pellet This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be... 
Via Benzinga
14 Stocks in the Healthcare Sector
Here are 14 companies in the Healthcare Sector that have investment-grade credit ratings of BBB- or better, cash flow yield of 6% or better, future total return of at least 5%. 
Via Talk Markets
7 Low Labor-Cost Stocks to Buy for Solid Margins in 2022
These seven low-labor-cost stocks -- including Apple and PayPal -- are buys as the U.S. labor market tightens and wages rise in 2022. 
Via InvestorPlace
Cardinal Health Expects Inflationary Impact, Supply Chain Constraints To Hit Volumes In FY22
Cardinal Health Inc (NYSE: CAH) shares are trading lower after the company warned of additional inflationary effects and lower volumes from global supply chain constraints... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Molecular Partners (NASDAQ:MOLN) shares rose 26.6% to $20.9 during Monday's pre-market session. The company's market cap stands at $674.6 million. Apria (... 
Via Benzinga
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.